Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma
Abstract Inflammation promotes tumor progression, induces invasion and metastatic spread. This retrospective study explored CRP, CA19-9, and routine laboratory values as preoperative prognostic factors in pancreatic cancer patients. Between 2000 and 2016, there were 212 surgically treated pancreatic...
Guardado en:
Autores principales: | Anna M. Nurmi, Harri K. Mustonen, Ulf-Håkan Stenman, Hanna E. Seppänen, Caj H. Haglund |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/35f47949fb5443f58bdec73b950f1d0b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer
por: Annika Eurola, et al.
Publicado: (2021) -
Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma
por: Farzad Khalvati, et al.
Publicado: (2019) -
Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma
por: Sachie Kiryu, et al.
Publicado: (2021) -
Robust deep learning model for prognostic stratification of pancreatic ductal adenocarcinoma patients
por: Jie Ju, et al.
Publicado: (2021) -
Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma
por: Cheng-Wei Chou, et al.
Publicado: (2021)